Breast cancer can eventually develop brain metastases in 40–50% of cases in HER2-positive BC and TNBC, and this risk can further increase in cases of BRCA1/2-mutated patients affected by TNBC. This evidence concerns the gene BRCA1 and breast carcinoma.